| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |